<SEC-DOCUMENT>0001437749-24-021877.txt : 20240702
<SEC-HEADER>0001437749-24-021877.hdr.sgml : 20240702
<ACCEPTANCE-DATETIME>20240702092906
ACCESSION NUMBER:		0001437749-24-021877
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240627
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240702
DATE AS OF CHANGE:		20240702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYADIC INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001213809
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				450486747
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32513
		FILM NUMBER:		241093093

	BUSINESS ADDRESS:	
		STREET 1:		1044 NORTH U.S. HIGHWAY ONE
		STREET 2:		SUITE 201
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477
		BUSINESS PHONE:		561-743-8333

	MAIL ADDRESS:	
		STREET 1:		1044 NORTH U.S. HIGHWAY ONE
		STREET 2:		SUITE 201
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCP WORLDWIDE INC
		DATE OF NAME CHANGE:	20030110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dyai20240627_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dyai="http://www.dyai.com/20240701"><head><!-- Generated by ThunderDome Portal - 7/2/2024 1:27:44 PM -->
	<title>dyai20240627_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 7/2/2024 1:27:44 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body class="vsc-initialized" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-316">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-317">0001213809</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="dyai-20240701.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001213809</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-07-01</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin: 0pt; text-align: center;"><b>UNITED STATES</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Washington, D.C. 20549</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#160;</td>
			<td style="vertical-align:bottom;width:33%;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; margin: 0pt; text-align: center;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-22"><b><b>8-K</b></b></ix:nonNumeric></b></div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;; font-size: 14pt;">
			<td style="vertical-align: bottom; width: 32.9%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#160;</td>
			<td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 34.1%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&#160;</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Date of Report (date of earliest event reporte<span style="background-color:#ffffff;">d): <ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-44"><b><span style="background-color:#ffffff;"><b><span style="background-color:#ffffff;"><b><span style="background-color:#ffffff;"><span style="text-decoration: underline;"><span style="font-family:Times New Roman;font-size:12pt;">June 27</span></span></span></b></span><span style="background-color:#ffffff;"><b><span style="background-color:#ffffff;"><span style="text-decoration: underline;"><span style="font-family:Times New Roman;font-size:12pt;">, 2024</span></span></span></b></span></b></span></b></ix:nonNumeric></span></b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#160;</td>
			<td style="vertical-align:bottom;width:33%;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-67"><b>Dyadic International, Inc.</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#160;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#160;</td>
			<td style="vertical-align:bottom;width:33%;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-83"><b>Delaware</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(State or other jurisdiction of incorporation or organization)</div>
			</td>
			<td style="vertical-align:top;width:34.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-88"><b>000-55264</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-93"><b>45-0486747</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(I.R.S. Employer Identification Number)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-99"><b>1044 North U.S. Highway One, Suite 201</b></ix:nonNumeric><br/>
			<ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-102"><b>Jupiter</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressStateOrProvince" id="ixv-105"><b><b>FL</b></b></ix:nonNumeric> <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-108"><b><b>33477</b></b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;">(Address of principal executive offices and zip code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><b>(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-118"><b><b>561</b></b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-121"><b><b>743-8333</b></b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;">(Registrant&#8217;s telephone number, including area code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><b>N/A</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><b>(Former Name or Former Address, if Changed Since Last Report)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-327">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-328">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-329">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-330">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Securities registered pursuant to Section 12(b) of the Act</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 39.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:left;">Title of each class</div>
			</td>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 19.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">Trading Symbol(s)</div>
			</td>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 41.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 39.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:left;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle" id="ixv-331">Common Stock</ix:nonNumeric>, par value $0.001 per share</div>
			</td>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 19.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol" id="ixv-332">DYAI</ix:nonNumeric></div>
			</td>
			<td style="vertical-align: bottom; border: 1px solid rgb(0, 0, 0); width: 41.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">The <ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-333">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:right;">Emerging growth company <ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-334">&#9744;</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><b>&#160;</b></div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">On June 27, 2024, Dyadic International, Inc. (&#8220;Dyadic&#8221;) entered into a License and Development Agreement (the &#8220;Agreement&#8221;) with Proliant Biologicals, LLC d/b/a Proliant Health and Biologicals (&#8220;Proliant&#8221;), pursuant to which Proliant will license Dyadic&#8217;s proprietary fungal microbial expression and production platforms and microbial strains from Dyadic for the production of recombinant serum albumin.&#160;Under the terms of the Agreement, Dyadic will receive an initial upfront payment of $500,000. Dyadic will receive a second payment of $500,000 upon the completion of the transfer of a Production Strain (as defined in the Agreement.) Dyadic will receive a final payment of $500,000 upon the meeting of a certain productivity threshold. Dyadic also will receive a share of the profits received by Proliant from the sale of animal-free recombinant serum albumin products produced pursuant to the Agreement. The foregoing description of the Agreement is only a summary of the material terms thereof, does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="background-color:#ffffff;">Item 7.01 Regulation FD Disclosure.</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">On June 28<span style="background-color:#ffffff;">, 2</span>024, Dyadic&#160;issued a press release related to the Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference, other than the third and fourth&#160;paragraphs&#160;of the press release.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -3pt; text-indent: 18pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td colspan="3" style="vertical-align:middle;width:100.5%;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 2pt; text-align: left;"><b><span style="background-color:#ffffff;">Item 9.01 Financial Statements and Exhibits</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:24.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><span style="background-color:#ffffff;">(d) Exhibits</span></div>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:75.4%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:24.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><b><span style="background-color:#ffffff;">Exhibit</span></b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><span style="text-decoration: underline;"><b><span style="background-color:#ffffff;">Number</span></b></span></div>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:75.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><span style="text-decoration: underline;"><b><span style="background-color:#ffffff;">Description</span></b></span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:24.3%;">&#160;</td>
			<td style="vertical-align:bottom;width:0.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:75.4%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 24.3%; text-align: center;"><span style="background-color:#ffffff;">10.1</span><sup style="vertical-align:top;line-height:120%;"><span style="background-color:#ffffff;">(1)</span></sup></td>
			<td style="vertical-align:bottom;width:0.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:75.4%;"><a href="ex_693312.htm" style="-sec-extract:exhibit;">License and Development Agreement between Dyadic International, Inc. and Proliant Biologicals, LLC d/b/a Proliant Health and Biologicals, dated June 27, 2024.</a></td>
		</tr>
		<tr>
			<td style="vertical-align:top; width:24.3%; text-align:center"><span style="background-color:#ffffff;">99.1</span></td>
			<td style="vertical-align:bottom; width:0.8%">&#160;</td>
			<td style="vertical-align:bottom; width:75.4%"><a href="ex_693313.htm" style="-sec-extract:exhibit;"><span style="background-color:#ffffff;">Dyadic International, Inc. Press Release Dated June 28, 2024</span></a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 24.3%; text-align: center;"><span style="background-color:#ffffff;">104</span></td>
			<td style="vertical-align:bottom;width:0.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:75.4%;"><span style="background-color:#ffffff;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><sup style="vertical-align:top;line-height:120%;"><span style="background-color:#ffffff;">(1)</span></sup>Certain provisions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><span style="background-color:#ffffff;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><span style="background-color:#ffffff;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><span style="background-color:#ffffff;">Date: July&#160;02, 2024</span></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:39.5%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td colspan="2" style="vertical-align:bottom;width:101.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Dyadic International, Inc.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:79.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>By:</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">/s/ Mark A. Emalfarb</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Name:</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Mark A. Emalfarb</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Title:</b></div>
			</td>
			<td style="vertical-align:bottom;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Chief Executive Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_693312.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_693312.htm</title>
	<!-- Generated by ThunderDome Portal - 7/1/2024 2:03:38 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="1" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Portions of this Exhibit have been redacted because they are both (i) not material and (ii) would be competitively harmful if publicly disclosed. Information that was omitted has been noted in this document with a placeholder identified by the mark</i></b>&nbsp;<b>"</b><b><i>[***]</i></b>&#8221;<b><i>.</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>LICENSE AND DEVELOPMENT AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">This LICENSE AND DEVELOPMENT AGREEMENT (the &#8220;Agreement&#8221;) is entered into as of the date of last signature by and between Dyadic International (USA) Inc., a Florida corporation with offices at</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1044 US-1 North, Suite 201 Jupiter, FL 33477 (&#8220;Dyadic&#8221;) and Proliant Biologicals, LLC, an Iowa Limited liability company, d /b /a Proliant Health and Biologicals, with offices at _2425 SE Oak Tree Ct., Ankeny, IA 50021 (&#8220;PHB&#8221;). Dyadic and PHB are each referred to as a &#8220;Party&#8221; and collectively as the &#8220;Parties.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WHEREAS, Dyadic is a company engaged in the development of commercial strains using proprietary fungal microbial expression and production platforms (&#8220;Technology&#8221;), which include but are not limited to the expression platforms known as &#8220;C1 Platform&#8221; and &#8220;Dapibus&#8482;.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WHEREAS, Dyadic has developed and may further develop in the future, using the Technology, microbial strains for production of recombinant serum albumin (&#8220;Production Strains&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WHEREAS, PHB wishes to license such Technology and Production Strains from Dyadic for the production of recombinant serum albumin, (the &#8220;Products&#8221;) for use in certain applications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>1.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;Definitions.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>1.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Defined Terms. </i>For purposes of this Agreement, the following capitalized terms shall have the meanings specified in this Section 1.1 unless the context requires otherwise.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Affiliates&#8221; is any company controlling, controlled by, or under common control with a Party, with &#8220;control&#8221; meaning directly or indirectly owning or controlling at least fifty percent (50%) of such companies voting stock, or possessing the power to direct or cause the direction of its management and policies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Background IP&#8221; means the Intellectual Property belonging to a Party which was developed prior to this Agreement and/or which is developed by a Party during the Term of this Agreement, but such development is not pursuant to or related to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Confidential Information&#8221; means the existence of this Agreement and the related discussions together with all information that Receiving Party acquires from the Disclosing Party, whether developed by the Disclosing Party and/or any of its Affiliates (as defined below) or by others and whether patented or patentable, including, without limitation, the following information of the Disclosing Party or any of its Affiliates: customer and supplier lists, trade secrets, designs, processes, formulas, audit information, ingredients, business plans and strategies, financial or tax information, compensation information, pricing information, specifications, devices, research and development data, manufacturing and processing data, clinical and engineering data, purchasing and marketing data, samples, and the like of every kind, and all information the Receiving Party acquires or observes in connection with this Agreement and the related discussions, regardless of whether such information is designated as &#8220;Confidential Information&#8221; at the time of its disclosure .Notwithstanding the foregoing, Confidential Information will not include information which (a) is generally known to the public at the time of disclosure by or on behalf of the Disclosing Party or later becomes so generally known through no fault of the Receiving Party; (b) was known to the Receiving Party, or otherwise in its possession, prior to disclosure by the Disclosing Party; (c) is disclosed to the Receiving Party by a third party who did not obtain such information, directly or indirectly, from the Disclosing Party subject to any confidentiality obligation; or (d) is at any time independently developed by the Receiving Party without the use of any Confidential Information of the Disclosing Party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: right;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Developed IP&#8221; means any and all Intellectual Property that is conceived or created, by either Party, or the Parties jointly, arising from the activities of one or both Parties pursuant to, or relating to this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Disclosing Party&#8221; means the Party, or Affiliate of such Party, from time to time disclosing Confidential Information to the Receiving Party or Affiliates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Field&#8221; <i>[***]</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Gross Margin&#8221; means Net Sales less all costs of goods sold (&#8220;COGS&#8221;) as determined by US Generally Accepted Accounting Principles (&#8220;US GAAP&#8221;). COGS shall include any and all costs associated with manufacturing, packaging, and storing the Products. Costs included in COGS includes, but is not limited to, upstream processing costs, chemicals, utilities, labor and related benefit costs, , packaging materials, transportation costs to obtain production materials, lab costs to test quality of Product and equipment and building costs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Intellectual Property&#8221; means: (A) patents, patent applications of any kind, patent rights, inventions, discoveries, and invention disclosures (whether or not patented or patentable); (B) registered and unregistered trademarks, service marks, trade names, trade dress, logos, packaging design, slogans and Internet domain names, and registrations and applications for registration of any of the foregoing; (C) copyrights in both published and unpublished works, including, without limitation, all compilations, databases and computer programs, manuals and other documentation and all copyright registrations and applications, and all derivatives, translations, adaptations and combinations of the above; (D) all know-how, trade secrets, confidential or proprietary information, research in progress, algorithms, data, designs, processes, formulae, drawings, schematics, blueprints, flow charts, models, strategies, prototypes, techniques, beta testing procedures and beta testing results; and (E) any and all other intellectual property rights and/or proprietary rights relating to any of the foregoing in any jurisdiction throughout the world.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Net Sales&#8221; means the total dollar value collected by PHB through sales of Products less the cost of sales returns, allowances and discounts. Amount determined in accordance with US GAAP.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Production Strains&#8221; includes the existing strains described in Schedule 3 and any other strains that produce serum albumin that currently exist or are later developed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Receiving Party&#8221; means the Party, or an Affiliate of such Party, from time to time receiving Confidential Information from the Disclosing Party or its Affiliates.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;Territory&#8221; shall mean the entirety of the world, <i>i.e.</i>, global.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: right;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>1.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Other Definitions. </i>Other capitalized terms used in this Agreement shall have the meanings respectively ascribed to them herein.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>License.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>2.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB is herein granted an exclusive right and license to use the Production Strain(s) to produce, market, and commercialize the Products for the Fields throughout the Territory.<b>&nbsp;&nbsp;</b>The license to use the Production Strain(s) shall also include a license to use the Technology to the extent the use of the Technology is necessary for use of the Production Strain(s).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>2.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB is granted &#8220;have made&#8221;&nbsp;rights to enable 3<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;Parties to use the Production Strain(s) and/or Technology to produce Products for PHB. Each 3<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;Party shall be subject to all terms and conditions set forth herein. For clarity, the &#8220;have made&#8221;&nbsp;rights that PHB provides to 3<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;Parties shall not be and cannot be greater than the rights conveyed to PHB in this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>3.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Development of Improved Production Strains.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>3.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Development Program. </i>At PHB&#8217;s request, and upon mutual written agreement between the Parties, Dyadic will conduct a phased development program (&#8220;Development Program&#8221;) for further development of the Production Strains pursuant to an agreed upon written plan (&#8220;Development Plan&#8221;). The Development Plan, including funding provisions, milestones, timelines, and goals, shall be the subject of a separate agreement between the Parties. For clarity, PHB is under no obligation to request and fund any Development Program, but rather it is in PHB&#8217;s sole discretion whether to request and fund such a Development Program.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>3.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>License to Further Developments. </i>&nbsp;PHB will be automatically granted an exclusive license within the Field for any improved or new Production Strains that result from that plan, such exclusive license being otherwise governed by the terms of this Agreement, including the requirement to pay Royalties.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>4.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Right of First Negotiation for Recombinant Transferrin </b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>4.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB is granted a right of first negotiation for any production strains that Dyadic may develop in the future for production of recombinant Transferrin (&#8220;Transferrin Strain&#8221;), pursuant to the terms of this Section 4.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>4.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Dyadic shall notify PHB within a commercially reasonable time after developing a Transferrin production strain. Within sixty (60) days following the receipt of a such notice from Dyadic, the Parties shall endeavor to negotiate in good faith a mutually acceptable license agreement. If the Parties fail to execute a license agreement within six (6) months from the date of the disclosure to PHB, the right of first negotiation discussed in this Section 4 shall expire, provided that, for a period of one (1) year after the termination of the negotiations with PHB, Dyadic shall not enter into such a license with a third party on terms that are more favorable than the terms last offered to PHB, without first offering such terms to PHB. PHB shall have thirty (30) days to accept or reject such terms after which Dyadic shall have no further obligation to PHB with respect to the Transferrin Strain.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: right;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>5.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Payments</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>5.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>License Fee:</i>&nbsp;PHB will pay to Dyadic a fee of $1,500,000.00 (USD) for the exclusive license granted herein (&#8220;License Fee&#8221;). The License Fee shall be paid according to the schedule set forth below:</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">i.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">within seven (7) days of complete execution of this Agreement, an initial payment of $500,000;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">ii.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">within seven (7) days of Dyadic delivering to PHB a Production Strain that produces Human Serum Albumin (USP sequence as shown in Schedule 1) (&#8220;USP-HSA&#8221;), a second payment of $500,000; and</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">iii.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">after Dyadic delivers to PHB a Production Strain, PHB will use commercially reasonable efforts to confirm that the Production Strain provides productivity [***] meets this productivity threshold, will make a third payment of $500,000.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 62pt;">Dyadic shall reinvest $500,000 of the License Fee associated with Section 5.1 iii into tech transfer, further research and development, scale up, regulatory support, and/or commercialization activities, to be mutually agreed upon between the Parties in writing, to further the commercial production of the Products.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>5.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Royalties:</i>&nbsp;Upon commencing commercial sales of a Product, PHB will begin to pay Dyadic, on a quarterly basis, a royalty equal to [***] of the Gross Margin received by PHB for all sales of the Products (&#8220;Royalty&#8221;). Such Royalty payments shall be made to Dyadic forty-five (45) days after the end of the calendar quarter and shall include an accounting of all sales made in the most recent calendar quarter and the Royalty owed for those sales.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>6.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Buyout Provision</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">In the event that a third party endeavors to wholly purchase and/or license a Product or Production Strain for the Fields in the Territory for a lump sum cash payment (&#8220;3rd Party Purchase&#8221; offer), and Dyadic wishes to accept that 3rd Party Purchase offer, PHB will have the option to either (a) allow the 3rd Party Purchase to be consummated, in which case PHB will be entitled to [***] of the total purchase price, or (b) reject the 3rd Party Purchase offer and buy out Dyadic&#8217;s interest in that offer by paying Dyadic (based on the [***] of Gross Margin set forth above), at which point PHB&#8217;s license will become a fully paid exclusive license for that Product or Production Strain for that Field in the Territory such that no further royalty payments will be owed to Dyadic. For example, if a 3rd Party makes a formal proposal to wholly purchase and/or license a Product or Production Strain in a Field in the Territory at a purchase price of [***], and Dyadic wishes to accept the 3<sup style="vertical-align:top;line-height:120%;">rd</sup> Party Purchase offer then PHB can elect to either (a) allow that deal to be consummated, which would entitle PHB to [***] from the sale and Dyadic to [***] from the sale, or (b) not allow the deal to be consummated by paying Dyadic [***], which then gives PHB a fully paid exclusive license for that Product or Production Strain for that Field in the Territory.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>7.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Regulatory Approval</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>7.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB will be responsible for obtaining and maintaining any regulatory approval necessary or customary to support the use and commercialization of any Products produced using the Production Strain(s) throughout the Territory.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>7.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Each Party will have access to, and the right to use, or reference, regulatory filings developed by the other Party in connection with the Production Strains, including data used in the support of such regulatory filings for the Products (a) for PHB with respect to the Products produced using the Production Strain(s) in the Fields in the Territory and (b) for Dyadic to support the Technology generally.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>8.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Intellectual Property</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>8.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Each Party shall retain all right, title, and interest in and to all of its Background IP, including the right to transfer or license those rights to third parties for any purpose, subject only to the rights granted to the other Party pursuant to this Agreement and to its obligations under this Agreement and under Dyadic&#8217;s rights to sublicense the Technology under the terms and conditions of its relevant license with Danisco US.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>8.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">All Developed IP shall be owned by the Party that conceived and created that development or, if jointly developed, shall be jointly owned.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>9.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;Availability of Commercialization Materials</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">At PHB&#8217;s discretion, commercialization materials will be made available to Dyadic to allow Dyadic to support the Product(s) within the Territory. For clarity, these materials may include but are not limited to: (i) link to PHB website or ordering system hosted on Dyadic&#8217;s website; (ii) marketing materials and resources for conferences, conventions, tradeshows, or related marketing events; and (iii) applicable scientific publications or literature. Dyadic support for the Product(s) within the Territory will be approved by PHB prior to implementation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>10.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Records and Audit:</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>10.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB and<i>&nbsp;</i>its Affiliates and Approved Subcontractors shall maintain full and accurate English language, written, computerized records for all Products sold or otherwise distributed in accordance with sound business practices. Such records shall include at least dates, quantities, and prices at which all Products were sold (&#8220;Records&#8221;). Such Records must be kept during the term of this Agreement and for a period of three (3) years thereafter.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>10.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB shall make such Records available to a third-party accounting firm selected by Dyadic (&#8220;Auditor&#8221;) on five (5) business days&#8217;&nbsp;notice, in order to confirm compliance to this Agreement&#8217;s terms and conditions.<i>&nbsp;</i>&nbsp;The Auditor shall have the right to confidentially inspect such books and records upon reasonable advance notice and no more frequently than once per year to verify the amounts payable under this Agreement. The Auditor shall treat all such records as confidential and shall not provide Dyadic with any information that is not necessary for Dyadic to understand the results of the audit, including, but not limited to, the identities of PHB&#8217;s customers, suppliers, etc. If requested by PHB, the Auditor will sign an appropriate confidentiality agreement. Dyadic shall bear the fees and expenses of such audit, provided that if an underpayment is discovered, PHB shall promptly pay to Dyadic any amounts due and unpaid together with interest on such unpaid amount at the U.S. prime rate quoted in The Wall Street Journal on the first business day after such unpaid amount is discovered and, if such underpayment constitutes an error of five percent (5%) or more for the year audited, PHB shall additionally reimburse Dyadic for the costs and expenses of such audit.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>11.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Representations and Warranties.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>11.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>By Dyadic. </i>Dyadic represents, warrants, and covenants the following to PHB:</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(a)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">This Agreement has been duly and validly executed and delivered by Dyadic and constitutes its valid and legally binding obligation enforceable in accordance with its terms.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(b)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To Dyadic&#8217;s knowledge, use of the Technology and Production Strain(s) to make and sell Products in the Field does not misappropriate or infringe any third-party Intellectual Property rights.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(c)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Dyadic will use commercially reasonable and diligent efforts with respect to those activities for which it is responsible under this Agreement consistent with the efforts that it would and does expend for its own high priority projects. This shall include but not limited to, supporting and assisting PHB in its efforts to seek regulatory approvals for and to market the Products for use in the Fields throughout the Territory, in a prompt and expeditious manner.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>11.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>By PHB. </i>PHB represents, warrants, and covenants the following to Dyadic:</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(a)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">This Agreement has been duly and validly executed and delivered by PHB and constitutes its valid and legally binding obligation enforceable in accordance with its terms.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(b)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">As further defined in Schedule 2, following delivery of a Production Strain to PHB, PHB will use commercially reasonable and diligent efforts to actively pursue development of and regulatory approvals for Products in the Field throughout the Territory and, following the receipt of all necessary approvals, will use commercially reasonable efforts to launch, market, promote, and sell such Products within the Field throughout the Territory, within a commercially reasonable time period. For clarity, PHB shall be under no obligation to launch, market, promote, or sell Products unless and until the productivity threshold of section 5.1.iii is obtained.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>(c)</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">PHB will use commercially reasonable and diligent efforts with respect to those activities for which it is responsible under this Agreement consistent with the efforts that it would and does expend for its own high priority projects. This shall include, but not be limited to, efforts necessary to actively pursue development and regulatory approvals for and to market the Products for use in the Fields throughout the Territory, in a prompt and expeditious manner.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>12.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;Term; Termination.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>12.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Term. </i>Unless terminated earlier in accordance with Section 12.2, this Agreement shall commence on June 27, 2024 (&#8220;Effective Date&#8221;) and shall remain in effect for an initial period of ten (10) years from the Effective Date (&#8220;Initial Term&#8221;). PHB shall have, in its sole discretion, the right to extend the term of this Agreement by additional successive three (3) year terms (&#8220;Extension Terms&#8221;) for so long as development, marketing, and/or sales of Products are being actively pursued by PHB. Notwithstanding the above, the Parties can mutually agree to terminate this agreement at any time.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>12.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Termination. </i>Either Party may terminate this Agreement for an uncured breach by the other Party after providing the breaching Party written notice of the breach and a period of thirty (30) days to cure the breach.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>12.3</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Survival; Effect of Expiration or Termination.</i>&nbsp;On expiration of this Agreement (including the Initial Term and any relevant Extension Terms) pursuant to Section 12.1, the license rights granted hereunder shall convert from exclusive to non-exclusive and the requirement for PHB to make Royalty payments pursuant to Section 5 shall terminate.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>12.4</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Notwithstanding anything contained in this Agreement, the Parties hereby agree that, in the event either of the Parties: (i) is declared bankrupt or insolvent by a court of competent jurisdiction in accordance with the relevant applicable law; or (ii) ceases to carry on its business, then, in the case of PHB if Dyadic is declared bankrupt or insolvent or ceases to carry&nbsp;out its business, it shall continue to have all rights to use the Production Strains as granted in Section 2.1 of the Agreement so long as it continues to make all payments specified under this Agreement, from the date of order of such competent court or the date of cessation to carry on the business, as the case may be. Alternatively, if PHB is declared bankrupt or ceases to carry on its business then the license to the Production Strains granted in Section 2.1 of this Agreement will be terminated and Dyadic will be free to license the Production Strains to any other entity.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>13.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;Protection of Confidential Information</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>13.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Restrictions on Disclosure and Use. </i>The Receiving Party shall use Confidential Information only in furtherance of the conduct of this Agreement and the activities contemplated thereunder and not (except as explicitly permitted by this Agreement) disclose it to anyone without the prior written consent of the Disclosing Party. The Receiving Party shall restrict access to Confidential Information to those of the Receiving Party&#8217;s Affiliates and personnel required to have knowledge thereof for the exercise of right or performance of obligations under this Agreement. The Receiving Party shall procure that the Receiving Party&#8217;s Affiliates and personnel will act in accordance with the confidentiality and non-use provisions of this Agreement as if each of them were a party hereto. Any non-compliance with any of the provisions of this Agreement by any Receiving Party&#8217;s Affiliates or personnel shall be deemed a breach of this Agreement by the Receiving Party.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>13.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Compelled Disclosure. </i>If the Receiving Party becomes compelled by judicial or administrative process or is required by applicable law or any governmental or other authority or by any applicable contract or regulations of any applicable stock exchange to disclose any Confidential Information of the Disclosing Party, the Receiving Party shall promptly notify the Disclosing Party in order for the Disclosing Party to seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement, and the Receiving Party shall co-operate with the Disclosing Party regarding any action which the Disclosing Party may decide to take to challenge the validity of such requirement or the manner of disclosure.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>13.3</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Public Announcements. </i>The Parties will agree upon the content of a press release for joint release to the public regarding the execution of this Agreement. Neither Party shall issue any other public announcement, press release or other public disclosure regarding this Agreement or its subject matter without the other Party&#8217;s prior written consent, except for any such disclosure that is, in the opinion of the disclosing Party&#8217;s counsel, required by Applicable Law or the rules of a stock exchange on which the securities of the disclosing Party are listed (or to which an application for listing has been submitted). In the event a Party is, in the opinion of its counsel, required by Applicable Law or the rules of a stock exchange on which its securities are listed (or to which an application for listing has been submitted) to make such a public disclosure, such Party shall submit the proposed disclosure in writing to the other Party as far in advance as reasonably practicable (and in no event less than three Business Days prior to the anticipated date of disclosure) so as to provide a reasonable opportunity to comment thereon.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>14.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Third Party Infringement.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>14.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Notice.</i>&nbsp;&nbsp;In the event either Party becomes aware of any suspected third-party infringement of any Intellectual Property rights of either Party relevant to this Agreement (an &#8220;Infringement&#8221;), that Party shall promptly notify the other Party and provide it with all details of such Infringement of which it is aware (each, an &#8220;Infringement Notice&#8221;). The Parties shall promptly meet to discuss the Infringement and to determine the collective overall strategy for patent enforcement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>14.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Right to Enforce.</i>&nbsp;&nbsp;Unless otherwise determined by the Parties, in the event that an Infringement occurs, the Party whose intellectual property rights are alleged to have been infringed shall have the first right and option to address such Infringement by taking reasonable steps, which may include the institution of legal proceedings or other action. All costs, including, without limitation, attorneys&#8217;&nbsp;fees, relating to such legal proceedings or other action shall be borne equally by the Parties.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>14.3</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Cooperation.</i>&nbsp;In any action, suit or proceeding instituted under this Article 14, the Parties shall cooperate with and assist each other in all reasonable respects. Upon the reasonable request of the Party instituting such action, suit or proceeding, the other Party shall join such action, suit or proceeding and shall be represented using counsel of its own choice, at the requesting Party&#8217;s expense.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>14.4</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Defense of Claims.</i>&nbsp;In the event that any action, suit or proceeding is brought against either Party or any Affiliate of either Party alleging the infringement of the Intellectual Property of a third party, such Party shall notify the other Party within ten (10) days of the earlier of (i) receipt of service of process in such action, suit or proceeding, or (ii) the date such Party becomes aware that such action, suit or proceeding has been instituted, and the Parties shall meet as soon as possible to discuss the overall strategy for defense of such matter. Each Party shall have the right to defend against actions brought against the Party. Each Party shall promptly furnish the other Party with a copy of each communication relating to the alleged infringement that is received by such Party including all documents filed in any litigation.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>15.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Indemnification</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Each Party (the &#8220;Indemnifying Party&#8221;) shall indemnify, defend and hold harmless the other Party, its Affiliates, their respective directors, officers, employees and agents, and their respective successors, heirs and assigns (each, an &#8220;Indemnified Party&#8221;) from and against all costs, fees, damage, loss, liability, expense or judgment (including attorneys&#8217; fees and expenses of litigation if assessed against the Indemnified Party by a court of competent jurisdiction) (collectively &#8220;Losses&#8221;) incurred by or imposed upon the Indemnified Parties, or any of them, as a direct result of (i) third party claims arising out of the development, manufacture, use or sale of any product by the Indemnifying Party or any of its Affiliates, sublicensees, distributors or agents, or (ii) the use of the Intellectual Property of the Indemnified Parties by the Indemnifying Party or any of its Affiliates, sublicensees, distributors or agents other than as expressly permitted by this Agreement; in either case except to the extent any Losses result from a material breach of this Agreement by, or the negligence or willful misconduct of, an Indemnified Party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>16.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Limitations of Liability</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXCEPT WITH RESPECT FOR LIABILITY ARISING UNDER CONFIDENTIALITY AND INDEMNIFICATION OBLIGATIONS UNDER THIS AGREEMENT, NO PARTY SHALL BE LIABLE TO THE OTHER PARTY UNDER THIS AGREEMENT FOR ANY INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR DAMAGES RESULTING FROM THE PERMITTED USE OF ANY INTELLECTUAL PROPERTY OR PROPRIETARY INFORMATION CREATED OR RECEIVED HEREUNDER, INCLUDING BUT NOT LIMITED TO LOST PROFITS, OR OTHER INDIRECT LOSS OR DAMAGE ARISING OUT OF THIS AGREEMENT AND/OR, OR ARISING OUT OF NEGLIGENCE OR WILLFUL CONDUCT CAUSING PERSONAL INJURY OR TANGIBLE PROPERTY DAMAGE OF A THIRD PARTY OR ANY RESULTING OBLIGATION, WHETHER IN AN ACTION FOR OR ARISING OUT OF BREACH OF CONTRACT, TORT, OR ANY OTHER CAUSE OF ACTION AND WHETHER OR NOT SUCH DAMAGES ARE FORESEEABLE.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>17.</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>General Terms.</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.1</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Entire Agreement.</i>&nbsp;This Agreement supersedes all prior and contemporaneous agreements, written or oral, between the Parties relating to the subject matter of this Agreement. This Agreement may not be modified, changed or discharged, in whole or in part, except by an agreement in writing signed by the parties hereto.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.2</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Section Headings</i>. The headings herein are inserted as a matter of convenience only, and do not define, limit, or describe the scope of this Agreement or the intent of the provisions hereof.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.3</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Compliance with Laws.</i>&nbsp;Each Party will comply with all applicable laws, regulations and guidelines during the course of performance of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.4</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Waiver. </i>Failure by either Party to enforce any provision of this Agreement shall not be deemed a waiver of future enforcement of that or any other provision.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.5</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Severability.</i>&nbsp;If for any reason a court of competent jurisdiction finds any provision of this Agreement, or portion thereof, to be unenforceable, that provision of this Agreement shall be enforced to the maximum extent permissible so as to affect the intent of the parties, and the remainder of this Agreement shall continue in full force and effect.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.6</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Governing Law and Waiver of Jury Trial</i>. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without any reference to any provisions regarding conflicts and/or choice of law. Exclusive jurisdiction of any disputes shall lie in the state and Federal courts located in New Castle County, Delaware, and each Party waives any objection to such venue and irrevocably submits to the jurisdiction of such courts. Such disputes will be adjudicated without the use of a jury and each Party hereby waives any right to a trial by jury.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.7</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Notices.</i>&nbsp;Notices and other formal communications under this Agreement shall be sent to the contact persons and addresses set forth below or otherwise notified by such Party, and shall be effective (i) if sent by reputable international courier, two days after dispatch, and (ii) if sent by registered mail, on confirmation of receipt, and (iii) if sent by e-mail, on receipt or a response indicating that such transmission was successful.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt; text-indent: 72pt;">If to Dyadic:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 45pt; text-indent: 36pt;">1044 US-1 North, Suite 201</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt; text-indent: 72pt;">Jupiter, FL 33477</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 45pt; text-indent: 36pt;">Attention: Mark Emalfarb</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt; text-indent: 72pt;"><i>[***]</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt; text-indent: 72pt;">If to PHB:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt; text-indent: 72pt;"><i>[***]</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.8</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Assignment. </i>This Agreement may not be assigned by either Party without the prior written consent of the other Party, such consent not to be unreasonably withheld or delayed; provided that either Party may convey this Agreement without such consent (i) to a successor in interest of substantially all of the business to which this Agreement relates, whether by assignment, merger, consolidation or otherwise, or (ii) to an Affiliate.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.9</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Counterparts. </i>This Agreement may be executed in any number of counterparts, which together shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page by facsimile shall be effective as delivery of a manually executed counterpart.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.10</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Further Assurances</i>. The Parties, without further consideration of any kind, shall each execute and deliver, or cause to be executed and delivered, such other instruments, and take, or cause to be taken, such other action, as shall reasonably be requested by another party hereto to more effectively carry out the terms and provisions of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.11</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Relationship of the Parties. </i>Neither Party shall represent itself as a partner, joint-venturer, agent, employee or general representative of the other. Each Party acknowledges that it shall have no right, power or authority to obligate in any way the other to any contract or other obligation.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.12</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Rights and Remedies. </i>All rights and remedies of either Party hereunder shall be cumulative and may be exercised singularly or concurrently. The failure of either Party, in any one or more instances, to enforce any of the terms of this Agreement shall not be construed as a waiver of future enforcement of that or any other term.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>17.13</i></b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Force Majeure. </i>Neither Party shall be held liable or responsible to the other Party, nor be deemed to have defaulted under or breached this Agreement, for failure or delay in fulfilling or performing any term of this Agreement when such failure or delay is caused by or results from causes beyond the reasonable control of the affected Party, including but not limited to fire, floods, embargoes, acts of war, insurrections, riots, civil commotions, strikes, lockouts or other labor disturbances, acts of God, pandemic, or acts, omissions or delays in acting by any governmental authority or the other Party.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:36pt;"><b>SIGNATURE PAGE TO FOLLOW</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">10</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURE PAGE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>DYADIC INTERNATIONAL (USA) INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:&nbsp;&nbsp;<u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u><u>/s/ Mark Emalfarb&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Name: Mark Emalfarb</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Title: President and Chief Executive Officer</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROLIANT HEALTH &amp; BIOLOGICALS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: <u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;/s/ <i>[***]</i>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Name: <i>[***]</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 18pt;">Title: President and Chief Executive Officer</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">SCHEDULE 1</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>[***]</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">SCHEDULE 2</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>[***]</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">SCHEDULE 3:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>[***]</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">14</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_693313.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_693313.htm</title>
	<!-- Generated by ThunderDome Portal - 6/28/2024 1:28:45 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-align: right;"><b>Exhibit 99.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="ex_693313img001.jpg" src="ex_693313img001.jpg" style="width:86;height:86;"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Jupiter, FL, June 28, 2024 (Globe Newswire) - </b>Dyadic International, Inc. (&#8220;Dyadic&#8221;) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">According to the terms of the agreement, Dyadic will receive an upfront milestone payment of $1.5MM and have agreed to a share of profits received by PHB from the sale of animal-free recombinant albumin products produced using Dyadic&#8217;s filamentous fungal microbial platforms. A portion of the upfront milestone payment will be allocated to the technology transfer and commercialization effort. The initial focus of the partnership will be the commercialization of recombinant human serum albumin products, with the anticipated launch of the first product in the first half of 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;We are excited to partner with Proliant Health and Biologicals, a global leader in the production of bovine serum albumin and other cell culture products for the life sciences industry. This partnership combines our collective experience and expertise to develop animal-free recombinant products for the approximately $6 billion serum albumin market.&#8221;, said Joe Hazelton, Dyadic&#8217;s Chief Operating Officer. &#8220;This agreement is a prime illustration of delivering on our strategy to commercialize products and generate near term revenue in the Alternative Proteins segment enabled by Dyadic&#8217;s microbial platforms. The combination of Dyadic&#8217;s protein production technology and PHB&#8217;s established market position provides a compelling opportunity to co-develop cost-effective, high-quality, high-volume products for the large and growing serum albumin market with applications in cell culture, vaccine, medical device and diagnostic segments.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Over the past few years, we have observed both increased interest and demand for alternative sources of protein for the diagnostic and life sciences industries. We are thrilled to partner with Dyadic to add animal-free protein sources to PHB&#8217;s product portfolio.&#8221;, said Chris Detzel, PHB&#8217;s Chief Executive Officer. &#8220;This partnership creates access to a technology with limitless potential for product innovation to meet customer and market demand. With this agreement we are excited to enter the animal-free protein space and begin supplying recombinant protein products that directly compete with traditional proteins on both total value and quality.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About Dyadic International, Inc.</b>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dyadic International, Inc. is a global biotechnology company focused on leveraging its innovative microbial protein production platforms to address the growing demand for cost effective recombinant proteins for applications including industrial, animal health and human health.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dyadic&#8217;s protein production platforms, C1 and Dapibus&#8482;, are based on the highly productive and scalable fungus&nbsp;<i>Thermothelomyces heterothallica</i> (<i>formerly Myceliophthora thermophila).</i>&nbsp;The platforms enable a rapid, clean and sustainable approach to produce high quality proteins at scales enabling a low cost of goods. Dyadic is leveraging the Dapibus platform to develop protein based products for the industrial, life sciences and next generation foods sector and leveraging&nbsp;the C1 platform to enable innovative life science companies to develop vaccines and therapeutics for the animal and human heath sectors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To learn more about Dyadic please visit&nbsp;www.dyadic.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About Proliant Health &amp; Biologicals: </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Proliant Health &amp; Biologicals is committed to the pursuit of a healthier future through the development of cutting-edge diagnostics, nutritional supplements, and therapeutics. As the world&#8217;s largest and most experienced manufacturer of purified bovine proteins, PHB is committed to the highest level of consistency, traceability, and quality in the market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">PHB is headquartered in Ankeny, Iowa, in addition to having manufacturing facilities in Boone, Iowa and Feilding, New Zealand.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Safe Harbor Regarding Forward-Looking Statements</b>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding Dyadic International&#8217;s expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance, such as the success of our alternative protein business, our internal programs and third-party collaborations. Actual events or results may differ materially from those in the forward-looking statements because of various important factors, including those described in the Company&#8217;s most recent filings with the SEC. Dyadic assumes no obligation to update publicly any such forward-looking statements, whether because of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled &#8220;Risk Factors&#8221; in Dyadic&#8217;s annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic&#8217;s periodic filings with the SEC, which are accessible on the SEC&#8217;s website and at&nbsp;www.dyadic.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic International, Inc.&nbsp;<br>
Ping W. Rawson&nbsp;<br>
Chief Financial Officer&nbsp;<br>
Phone:&nbsp;(561) 743-8333<br>
Email:&nbsp;ir@dyadic.com</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dyai-20240701.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 7/2/2024 1:27:48 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:dyai="http://www.dyai.com/20240701" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dyai.com/20240701">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20240701_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20240701_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20240701_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.dyai.com/20240701/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="dyai_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>dyai-20240701_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 7/2/2024 1:27:49 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.dyai.com/20240701/role/statement-document-and-entity-information" xlink:href="dyai-20240701.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.dyai.com/20240701/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>dyai-20240701_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 7/2/2024 1:27:48 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>dyai-20240701_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 7/2/2024 1:27:49 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.dyai.com/20240701/role/statement-document-and-entity-information" xlink:href="dyai-20240701.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.dyai.com/20240701/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex_693313img001.jpg
<TEXT>
begin 644 ex_693313img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !6 %8# 2(  A$! Q$!_\0
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MMMN["BBB@052UG_D!ZA_U[2?^@FKM4M9_P"0'J'_ %[2?^@F@J'Q(\H^"/\
MQ^ZM_P!<8?YM7KE__P @ZY_ZY/\ R->1_!'_ (_=6_ZXP_S:O7+_ /Y!US_U
MR?\ D:SI_ >IG'^_2^7Y(\6^#'_(U77_ %XG_P!#2O<:\.^#'_(TW7_7B?\
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MW6-;U6WL[/3;>,-"CRLRRRJK&21#\R+@+F,D%L9!KNK!;Q+15OI$DN,G<R#
MQGC]*$DE9!B,14Q%3VE3<LT444S **** "BBB@ J&XM+>Z\O[1!'+Y3B2/>H
M.UAD CT/)_.BB@"E<^'=&NX)(9]+M'CDC2)@8ARB9V#/HN3CTSQ3#X7T%K9+
M9M'L3"@550P*0 N=O;MN;_OH^M%% #CX;T0SP3_V39>;;JJ0N(%!C5>5 XX
1[>E:E%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139749961906912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">Dyadic International, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jun. 27,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-55264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">45-0486747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">1044 North U.S. Highway One, Suite 201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">743-8333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DYAI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001213809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M\2 9U$N:1+_.4AJRD069G#'URJSQSS^Y/><W!-@O@7U,?7P(8HL\LPW/M**
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( *)+XEAED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "B2^)8)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "B2^)899!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dyai20240627_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dyai.com/20240701/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>dyai-20240701.xsd</File>
    <File>dyai-20240701_def.xml</File>
    <File>dyai-20240701_lab.xml</File>
    <File>dyai-20240701_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="dyai20240627_8k.htm">dyai20240627_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dyai20240627_8k.htm": {
   "nsprefix": "dyai",
   "nsuri": "http://www.dyai.com/20240701",
   "dts": {
    "schema": {
     "local": [
      "dyai-20240701.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "dyai-20240701_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "dyai-20240701_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dyai-20240701_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "dyai20240627_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.dyai.com/20240701/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dyai20240627_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dyai20240627_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.dyai.com/20240701/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001437749-24-021877-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-021877-xbrl.zip
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M?9U;;R>-)]EJ]3:!G12>9*D56Q1V.GB2G-;OB]C)X556:K$+8^>8>9*65NP
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M\X5N^(@8X1)MH4SR!XM38Y XYD#("!+G>C* C (F:T&?\1(8WA[$95"I;@'
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MH+$,'7L)B_*'([]#^UP'SE-N=!:P'<^G5O21=9#+E@,-;(9(7LP\@3!M?B2
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MH>21N*QR0UE.E#11.=H)T.CU%]#-(I[I%P=?=J8?98W?_K!$,W+88AQBJU*
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M:\;JD]%9]_IFJV(*K:SRS[+ @Z=D@0</<@#XT$_#*6SHJ!C';_\?4$L#!!0
M   ( *)+XEC^\'>*<0L  & H   -    97A?-CDS,S$S+FAT;=U::W/;-A;]
MO/D5J+>3)C.2;-E)ZMB.9Y7$3IKFX3K9Z>Q^V0%!4$0#$BP 2E9__9X+@!+U
M<-.93O;A#XE%$@0N[N/<<R]X5OI*GY^5DN?G]_YRYI77\ES>_.O)TZ.C\=$(
M3\_VXTT\_68X9*]D+2WW,F?9@GTJVSJ7]J6I)+LRUG/-ANS)_N'Q_N'!X2,V
M/CD\/GGTF%V]8\/A^5DE/6>BY-9)_VRO]<7P>"_=K7DEG^T5QE;<#W/II?#*
MU'M,F-K+&J.]U+(I32V?U6;O_-[9?I3X+#/Y@CF_T.'UV@^=^DV>C \:?QHN
M"UXIO3CY[I.JI&/OY9Q=FXK7WYTV/,]5/3TY4#4;C55]2K,V:U.E=]G]7UOC
M3S=FB#=/V6I1%E:--V;<*E[[$U;3EO0IJ[B=JOJ$8<CRWS$-]_+&#[E64SRT
M:EIZ"'*6G5_<E"I3GCU].AJ?[6?G9_O-^;U;!-S>W"Y-="(EB9) ]!@+JFK*
MN(:>EZ;'G8.#\>B79KK'G!6W/8G2S%7NRY/C)Z>EI"W0K[VO+/+].G/-Z==<
M(UA&P;_Q].E_:,T_LL;&$OT5#F]9H>=D MN1=L/\V?G+!<^58#_0PYI3\'$]
MP*48,5[G[,H:31.RUQ)N4H9[SY719JH$UP[7M6EK(=FU%*;*5$UC)SIK*X37
M2SF3VC055@XOOC!5):U0$.BWL!2[XM8#5ERI&O;UO?U/J?BV%7HJ_J5U7A6+
M+1V_:1L%]0[8Y=L!>]/6DAT>#UA R@>OM,DDK>CFRLJ'@%'2P^]8Y<']OQX?
M'AZ<QB'A8GSZD#UX/_GX<O+3"7OYC\D/#P=+P^3,FYPOF"^YQW]RP4H^DRPX
M QZJVAO&6;YA*;%EJ:9GJ;F")WS),QY<O7Y.<C -P ;@,M<VC5;2,E.PIK6J
M4%B_L<9+53N@IR7Q6*[XM#;0HQBPNO56A=6#3%)K)EKM6RL)5C]+[T9WT&$F
M0A@;- ;3D$I@J<J1UNB"3ZV49*<!2TXR5]"+E4(JV)77K&T*BV49Y)/.(W/"
M=HM@64SQ[7CT^-V[H,_@!V$Z\A$8RB%#RV =:PKE73=IR/BP)L.\51#"<1T&
M\EIA1\,"<]#@)0#P! "8*&\%9HH_,%/K:&,KWQU_?PK;*\U)0-/B=UM/P28J
M):S)X'^LT=P3/W C-F$-N ;Y0U+&[5L-2D%@<:V-"*QEJ4Q1UN2E" G+:U?
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M!.1PD=#THB[L0ZN*.AIXW!CJ+L2,;GN)M#:S&-5XOY+P=Z1[;ZK$$5(,1$M
M;3%1K^';?"LO!::=\OD.Q34\A48FIW1-)'E!X;<!YWU$<9'-YR@8A ><!VP
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M:2TR,#(T,#<P,2YX<V102P$"% ,4    " "B2^)8?I0.S=<$  #D+   %0
M            @ &6 P  9'EA:2TR,#(T,#<P,5]D968N>&UL4$L! A0#%
M  @ HDOB6- ]$<#Y!0  0CP  !4              ( !H @  &1Y86DM,C R
M-# W,#%?;&%B+GAM;%!+ 0(4 Q0    ( *)+XE@Z+S3F<P0  'PM   5
M          "  <P.  !D>6%I+3(P,C0P-S Q7W!R92YX;6Q02P$"% ,4
M" "B2^)8F(B'HH$2  !W=@  $P              @ %R$P  9'EA:3(P,C0P
M-C(W7SAK+FAT;5!+ 0(4 Q0    ( *)+XEB9@$P3(38  "QR 0 -
M      "  20F  !E>%\V.3,S,3(N:'1M4$L! A0#%     @ HDOB6/[P=XIQ
M"P  8"@   T              ( !<%P  &5X7S8Y,S,Q,RYH=&U02P4&
/  < !P"_ 0  #&@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>dyai20240627_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dyai-20240701.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001213809</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-316">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-317">0001213809</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-22">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-44">2024-06-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-67">Dyadic International, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-83">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-88">000-55264</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-93">45-0486747</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-99">1044 North U.S. Highway One, Suite 201</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-102">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-105">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-108">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-118">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-121">743-8333</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-327">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-328">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-329">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-330">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20248K" id="ixv-331">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K" id="ixv-332">DYAI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K" id="ixv-333">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-334">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
